NLRP3 Inflammasome-Driven Pyroptosis and Brain-Derived Neurotrophic Factor in Cancer Drug Resistance: A Cell-Type-Resolved Framework
Year: 2026
Type: article
Abstract: Background/Objectives: Resistance to cancer therapy is attributed to the tumour microenvironment, not to tumour-cell genotype alone. Pyroptosis, the gasdermin-executed lytic death programme triggered mainly by NLRP3, is oncosuppressive in one compartment and resistance-promoting in another. We resolve that divergence by compartment and place brain-derived neurotrophic factor (BDNF) upstream. Methods: Narrative, mechanism-oriented review. Four queries covering the sensor, pyroptotic execution, malignancy and BDNF were screened on title and abstract; retained sources measured at least one step of the cascade, and claims were graded. Results: Acute activation in neoplastic cells releases damage-associated molecular patterns and supports immunogenic cell death, whereas chronic sublytic activation in M2-polarised tumour-associated macrophages sustains interleukin-1β/18 signalling, regulatory T-cell and myeloid-derived suppressor cell expansion, angiogenesis and checkpoint-blockade failure. BDNF restrains inflammasome activation in non-neoplastic systems through nuclear factor-κB priming, mitophagy, KLF2-dependent restraint of hexokinase 1, membrane repair and necroptosis crosstalk; no study has measured BDNF, NLRP3 and pyroptotic execution together in a tumour. Conclusions: We propose that BDNF may set this threshold in tumours, and a four-type classification by BDNF and NLRP3 status to organise experiment, not treatment. It makes compartment, duration and repair capacity, not the pathway’s presence, decide whether pyroptotic signalling favours or defeats therapy, and specifies what would falsify it.
Source: Medicina
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: NLRP3 inflammasome, pyroptosis, brain-derived neurotrophic factor, chemoresistance, tumor microenvironment, gasdermin, immunogenic cell death, tumour-associated macrophages, M2 macrophages, IL-1β, IL-18, regulatory T cells, myeloid-derived suppressor cells, angiogenesis, immune checkpoint blockade, NF-κB, mitophagy, KLF2, hexokinase 1, necroptosis, damage-associated molecular patterns
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7235741737
